Mark A. Munger
- Family Practice top 1%
- Medication Adherence and Compliance 7
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes 13
-
- Blood Pressure and Hypertension Studies 7
- Heart Failure Treatment and Management 7
- Atrial Fibrillation Management and Outcomes 5
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management 4
-
- Innovations in Medical Education 8
- Health and Medical Research Impacts 4
- Co-authors
- Benjamín Van TassellJoanne LaFleurMichael FeehanDavid HawkinsGreg StoddardDavid W. GraingerAkram M. ShaabanPrzemysław Radwański
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (9 papers)American Journal of Pharmaceutical Education (5 papers)JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (4 papers)
- Partner nations
- United StatesThailand
In The Last Decade
Mark A. Munger
51 papers receiving 945 citations
Peers
Comparison fields: 5 of 136
- Family Practice 156
- Geriatrics and Gerontology 180
- Cardiology and Cardiovascular Medicine 248
- Internal Medicine 32
- Applied Microbiology and Biotechnology 13
Countries citing papers authored by Mark A. Munger
This map shows the geographic impact of Mark A. Munger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Munger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Munger more than expected).
Fields of papers citing papers by Mark A. Munger
This network shows the impact of papers produced by Mark A. Munger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Munger. The network helps show where Mark A. Munger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark A. Munger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2020 | 9 | |
| 4 | 2020 | 21 | |
| 5 | 2019 | 2 | |
| 6 | 2019 | 9 | |
| 7 | 2019 | 1 | |
| 8 | 2019 | 7 | |
| 9 | 2013 | 47 | |
| 10 | 2013 | 30 | |
| 11 | 2013 | 156 | |
| 12 | 2010 | 4 | |
| 13 | Medication nonadherence: an unrecognized cardiovascular risk factor. | 2007 | 172 |
| 14 | 2004 | 58 | |
| 15 | 1996 | 8 | |
| 16 | 1993 | 5 | |
| 17 | Focus on fenoldopam: A dopaminergic agonist for severe hypertension | 1991 | 2 |
| 18 | 1991 | 14 | |
| 19 | 1990 | 19 | |
| 20 | 1988 | 10 |
About Mark A. Munger
Mark A. Munger is a scholar working on Geriatrics and Gerontology, Family Practice, Internal Medicine, Cardiology and Cardiovascular Medicine and Emergency Medical Services, having authored 54 papers that have together received 999 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (13 papers), Innovations in Medical Education (8 papers), Blood Pressure and Hypertension Studies (7 papers), Heart Failure Treatment and Management (7 papers), Medication Adherence and Compliance (7 papers), Atrial Fibrillation Management and Outcomes (5 papers), Health and Medical Research Impacts (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). The work is most often cited by research in Family Practice (156 citations), Geriatrics and Gerontology (180 citations), Cardiology and Cardiovascular Medicine (248 citations), Internal Medicine (32 citations) and Applied Microbiology and Biotechnology (13 citations). Mark A. Munger has collaborated with scholars based in United States and Thailand. Frequent co-authors include Benjamín Van Tassell, Joanne LaFleur, Michael Feehan, David Hawkins, Greg Stoddard, David W. Grainger, Akram M. Shaaban, Przemysław Radwański, Cassandra E. Deering‐Rice and Edward A. Panacek. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, American Journal of Pharmaceutical Education, JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Annals of Pharmacotherapy and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.